Menu
Recruiting NCT06665607

Foot Muscles Training in Sclerosis

No phase Interventional Multiple Sclerosis Muscle Weakness Training Group, Sensitivity

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Intrinsic Mucle Training.
Who it may be relevant to
Registry conditions: Multiple Sclerosis, Muscle Weakness, Training Group, Sensitivity. Basic parameters: 18 years — 70 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Spain
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Effects of Intrinsic Foot Muscles Training in Improving Stability in Multiple Sclerosis Patients

Overview

The study tries to assess the efficacy of an 8-week IFM training programme on stability in patients diagnosed with Multiple Sclerosis

Interventions

  • Procedure Intrinsic Mucle Training
    Conventional physiotherapy treatment and the intrinisc foot muscles strengthening program for 8 weeks.

Primary outcome measures

  • Four Square Step Test (FSST): dynamic stability assessment test. [Time frame: Initial and after 8 weeks]
  • Six Spot Step Test (SSST): test that quantitatively assesses lower limb function [Time frame: Initial and after 8 weeks]
  • The Frailty and Injuries: Cooperative Studies of Intervention Tecnhiques (FICSIT-4 test): Test of static balance [Time frame: 0-9 points. Initial and after 8 weeks]
  • Activities-specific Balance Confidence scale (AsBC) [Time frame: Initial and after 8 weeks]

Eligibility criteria

Inclusion criteria

  • Patients with moderate neurological disability as scored by the Expanded Disability Status Scale (EDSS), ranging from 3.0 to 6.0

Exclusion criteria

  • Cognitive disturbances that could affect the performance of any of the tests or questionnaires included in the study
  • Diagnosis of visual or vestibular disorders that could affect patient stability
  • Change in Multiple Sclerosis-specific medication in the 2 months prior to the start of the study
  • Acute relapse in the 2 months prior to the start of the study
  • Traumatologic or orthopaedic disorders that could negatively affect balance.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Triple blind
Primary purpose
Treatment

Study locations

Spain · 1 center
  • Universidad de Valladolid — Valladolid

Identifiers

NCT: NCT06665607 · FOOT TRAINING-SCLEROSIS

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗